late-stage testing
Alkermes Advances Narcolepsy Therapy with Promising Phase 2 Trial Results for Alixorexton
Alkermes; narcolepsy; alixorexton; Phase 2 trial; orexin 2 receptor agonist; narcolepsy type 1; normative wakefulness; late-stage testing; Vibrance-1 study; cataplexy; excessive daytime sleepiness
Regeneron Advances Anticoagulant Antibody Pair to Late-Stage Testing
Regeneron, anticoagulant, antibody, late-stage testing, Factor XI, REGN7508, REGN9933